Impero (IMPERO) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
27 Jul, 2026Executive summary
Achieved 15% year-over-year ARR growth to DKK 40.7M in H1 2025, with revenue up 21% and churn below 2%, and EBITDA loss reduced to DKK -4.2M from DKK -5.1M year-over-year.
Added 9 new customers across Germany, the UK, and Denmark, expanding the customer base and partner ecosystem, with strong upsell activity among large enterprises.
Launched new platform features, including Control Testing and a refreshed Administrator Dashboard, enhancing compliance and risk management capabilities.
Partnerships contributed 33% of new ARR, with increased engagement in Germany and expansion efforts in the UK and Benelux.
Leadership transition with new CFO Kasper Lihn appointed effective October 1, 2025.
Financial highlights
H1 2025 revenue increased 21% year-over-year to DKK 20.1M, with gross profit of DKK 11.0M and gross profit margin improved to 97%.
EBITDA for H1 2025 was negative DKK 4.2M, an improvement from negative DKK 5.1M in H1 2024; EBIT loss improved to DKK -5.9M from DKK -6.5M.
Cash position at end of H1 2025 was DKK 6.8M; equity reduced to DKK 0.2M due to growth investments.
Free cash flow for the last 12 months was negative DKK 7.8M, with a cash-to-acquired-ARR ratio of 1.5.
Outlook and guidance
Updated 2025 ARR guidance to DKK 43M–46M (11–19% growth), down from previous DKK 46M–49M; EBITDA guidance improved to DKK -6M to -4M.
On track to achieve cash flow positivity before end of 2026, with short-term free cash flow fluctuations expected.
Outlook assumes stable macroeconomic conditions and continued talent retention.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - Record ARR growth, positive EBITDA, and strong DACH performance drive raised 2025 outlook.IMPERO
Q3 202527 Jul 2026 - ARR grew 19% to DKK 46.2M in 2025, with EBITDA improving and churn at a low 1%.IMPERO
Q4 202527 Jul 2026 - 20% ARR growth, positive EBITDA, and strong DACH momentum drive upgraded 2026 outlook.IMPERO
Q1 202627 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026 - Strong ARR growth, AI-driven strategy, and all board proposals approved amid market uncertainties.IMPERO
AGM 202615 Apr 2026